NDC Active Ingredient Bortezomib

Active Ingredient Information

What is Bortezomib?

A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.

What is the usage for Bortezomib?

This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). It works by slowing or stopping the growth of cancer cells.

How many products in the NDC database contain Bortezomib?

The NDC database has 29 products with the active ingredient Bortezomib. The following table lists all the products that have this active ingredient.

NDC Products with Bortezomib

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0143-9098Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0409-1700Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHospira, Inc.ACTIVE
0409-1703Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHospira, Inc.ACTIVE
0409-1704Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousHospira, Inc.ACTIVE
0781-3258Proprietary Name: Bortezomib Bortezomib For InjectionInjection, Powder, Lyophilized, For SolutionIntravenousSandoz IncACTIVE
10019-991Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBaxter Healthcare CorporationACTIVE
25021-244Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousSagent PharmaceuticalsACTIVE
43598-426Proprietary Name: Bortezomib BortexomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousDr.reddy's Laboratories, Inc.ACTIVE
43598-865Proprietary Name: Bortezomib BortexomibInjection, Powder, Lyophilized, For SolutionIntravenousDr.reddy's Laboratories IncACTIVE
50742-484Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousIngenus Pharmaceuticals, LlcACTIVE
51817-586Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousPharmascience Inc.ACTIVE
55150-337Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousAuromedics Pharma LlcACTIVE
60505-6050Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousApotex CorpACTIVE
63020-049Proprietary Name: Velcade BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousTakeda Pharmaceuticals America, Inc.ACTIVE
63323-721Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenousFresenius Kabi Usa, LlcACTIVE
63323-821Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcACTIVE
67184-0530Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousQilu Pharmaceutical Co., Ltd.ACTIVE
68001-534Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBluepoint LaboratoriesACTIVE
68001-540Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBluepoint LaboratoriesACTIVE
68001-541Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousBluepoint LaboratoriesACTIVE
70511-161Proprietary Name: Bortezomib BortezomibInjectionIntravenousMaia Pharmaceuticals, Inc.ACTIVE
70511-162Proprietary Name: Bortezomib BortezomibInjectionIntravenousMaia Pharmaceuticals, Inc.ACTIVE
70710-1411Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousZydus Pharmaceuticals Usa Inc.ACTIVE
70771-1708Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousZydus Lifesciences LimitedACTIVE
70860-225Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousAthenex Pharmaceutical Division, Llc.ACTIVE
71288-118Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousMeitheal Pharmaceuticals Inc.ACTIVE
72205-183Proprietary Name: Bortezomib BortezomibInjection, Powder, Lyophilized, For SolutionIntravenous; SubcutaneousNovadoz Pharmaceuticals LlcACTIVE
72266-243Proprietary Name: Bortezomib BortezomibInjectionIntravenousFosun Pharma Usa IncACTIVE
72266-244Proprietary Name: Bortezomib BortezomibInjectionIntravenousFosun Pharma Usa IncACTIVE
<